CD44 and neoplasm: Biocompatible and biodegradable HA-coated CS NPs were developed to encapsulate a chemotherapeutic drug (5-Fu) to enhance drug accumulation in tumor cells and to improve the drug’s antitumor efficiency by achieving targeted drug delivery via CD44.